product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-c-Abl (Tyr412) (247C7) Rabbit mAb
catalog :
2865S
quantity :
100 ul
price :
274 USD
clonality :
monoclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/DilutionReference
  • western blot; human; 1:1000
Chatain N, Ziegler P, Fahrenkamp D, Jost E, Moriggl R, Schmitz-Van de Leur H, et al. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells. Oncogene. 2013;32:3587-97 pubmed publisher
Goss V, Lee K, Moritz A, Nardone J, Spek E, Macneill J, et al. A common phosphotyrosine signature for the Bcr-Abl kinase. Blood. 2006;107:4888-97 pubmed
O'Hare T, Zabriskie M, Eide C, Agarwal A, Adrian L, You H, et al. The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Blood. 2011;118:5250-4 pubmed publisher
product information
SKU :
2865S
Product-Name :
Phospho-c-Abl (Tyr412) (247C7) Rabbit mAb
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, (M)
Applications :
Western blot
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
135 (c-Abl); 210 (Bcr-Abl)
Host :
Rabbit
Target :
Abl1 (Tyr393) phosphate
Primary-Protein :
Abl
Alt-Names :
ABL,ABL1,Abelson murine leukemia viral oncogene homolog 1,JTK7,Proto-oncogene c-Abl,Tyrosine-protein kinase ABL1,bcr/abl,bcr/c-abl oncogene protein,c-ABL,c-abl oncogene 1, receptor tyrosine kinase,p150,proto-oncogene tyrosine-protein kinase ABL1,v-abl,v-abl Abelson murine leukemia viral oncogene homolog 1
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.